Genomics in Heart Transplants
Launched by HEINRICH-HEINE UNIVERSITY, DUESSELDORF · Aug 21, 2023
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Genomics in Heart Transplants," is studying how genetics and lifestyle factors affect the success of heart transplants. Researchers will analyze data from 200 heart transplant recipients, looking closely at their heart health, exercise habits, diet, and genetic information to understand what influences their recovery and overall outcomes. Additionally, they will collect detailed genetic information from 100 newly transplanted patients and their donors to explore how certain genetic traits might relate to the success of the transplant.
To participate in this study, you need to be at least 18 years old and planning to have a heart transplant at the research center. Unfortunately, if you're under 18 or unable to give consent, you won't be eligible for this trial. If you join, you can expect to undergo various tests and assessments that will help researchers learn more about the relationship between genetics and heart transplant outcomes. This information could lead to better care for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients \> 18 years old undergoing heart transplantation in our centre
- Exclusion Criteria:
- • \< 18 years
- • incapable of giving consent
About Heinrich Heine University, Duesseldorf
Heinrich-Heine University Düsseldorf is a leading academic institution dedicated to advancing medical research and education. Renowned for its innovative approach to healthcare and interdisciplinary collaboration, the university plays a pivotal role in clinical trials aimed at improving patient outcomes and translating scientific discoveries into clinical practice. With a robust infrastructure and a commitment to ethical standards, Heinrich-Heine University fosters an environment that supports cutting-edge research initiatives, contributing significantly to the advancement of medical knowledge and therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Düsseldorf, , Germany
Patients applied
Trial Officials
Malte Kelm, Prof.
Study Chair
Clinic for Cardiology, Pneumology and Angiology at University Hospital Düsseldorf
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported